penicillamine has been researched along with Clinical Deterioration in 1 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Clinical Deterioration: A critical disease progression, often measured by a set of clinical parameters, which activates HOSPITAL RAPID RESPONSE TEAM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rozina, T | 1 |
| Fastovets, S | 1 |
| Lee, O | 1 |
| Kuchieva, A | 1 |
| Bulanov, N | 1 |
| Moiseev, S | 1 |
1 other study available for penicillamine and Clinical Deterioration
| Article | Year |
|---|---|
D-penicillamine-induced autoimmune disorders.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Autoimmune Diseases; Autoimmunity | 2019 |